Use of deferoxamine (DFO) in transfusion-dependent β-thalassemia during pregnancy: A retrospective study
Objective: To report cases of use of chelation therapy during pregnancy which resulted in favorable outcomes for the babies. Materials and methods: In this retrospective cohort study, we described the evolution and outcome of 9 pregnancies in Italian thalassemic women who received deferoxamine (DFO)...
Saved in:
Main Authors: | Maria Grazia Piccioni (Author), Carmela Capone (Author), Flaminia Vena (Author), Valentina Del Negro (Author), Michele Carlo Schiavi (Author), Valentina D'Ambrosio (Author), Antonella Giancotti (Author), Maria Paola Smacchia (Author), Roberto Brunelli (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation and In-Vitro Characterization of Chitosan-Nanoparticles Loaded with the Iron Chelator Deferoxamine Mesylate (DFO)
by: Maria Lazaridou, et al.
Published: (2020) -
An overview of complications associated with deferoxamine therapy in thalassemia
by: Bijan Keikhaei, et al.
Published: (2021) -
Monochorionic-Diamniotic Twin Pregnancy Complicated by Spontaneous Septostomy and Cord Entanglement: A Systematic Review, Evaluation of Complication Rates and Presentation of an Additional Case
by: Chiara Boccherini, et al.
Published: (2022) -
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
by: Kontoghiorghe CN, et al.
Published: (2016) -
Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
by: Shahla Ansari, et al.
Published: (2017)